May 9, 2013
Whitehead Member Peter Reddien named an HHMI Investigator
The Howard Hughes Medical Institute (HHMI) announced today that Whitehead Member Peter Reddien is among 27 biomedical researchers nationwide to be appointed as HHMI investigators.
|
May 2, 2013 Scientists revolutionize the creation of genetically altered mice to model human diseaseUsing a bacteria-based technique, Whitehead Institute Founding Member Rudolf Jaenisch has efficiently created mouse models with multiple gene mutations in a matter of weeks. |
April 11, 2013 Genetic master controls expose cancers’ Achilles’ heelIn a surprising finding that helps explain fundamental behaviors of normal and diseased cells, Whitehead Institute scientists have discovered a set of powerful gene regulators dubbed “super-enhancers” that control cell state and identity. |
|
April 1, 2013 For third year running, Whitehead Institute takes top place for postdocsIn the final year of the “Best Places to Work: Postdocs” ranking, Whitehead Institute has again come out on top. This is the fourth time in 10 years that Whitehead has emerged as number one—more than any other institution in the history of the rankings, published annually by The Scientist magazine. |
March 28, 2013 Protective prion keeps yeast cells from going it aloneA team of scientists from Whitehead Institute and the University of Texas Southwestern Medical Center has added markedly to the job description of prions as agents of change, identifying a prion capable of triggering a transition in yeast from its conventional single-celled form to a cooperative, multicellular structure. This change, which appears to improve yeast’s chances for survival in the face of hostile environmental conditions, is an epigenetic phenomenon—a heritable alteration brought about without any change to the organism’s underlying genome. |
